Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #126

    Håber Novo og de andre drug makers står fast på at PBM skal afskaffes.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Scvej
      wrote on sidst redigeret af
      #127

      Jeg syntes fruergaard forsvarede Novo ret godt i sin senatshøring om netop priserne sidste år. Og det største problem ER jo PBM, hvordan det virksomhedslag kan få lov og drive forretning på den måde er vanvittigt

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #128

        Helt ening. Trump og hans kabinet MÅ da kunne se det er dårligt for økonomien med det ekstra led. Krydser fingre for at Novo kommer helskindet igennem processen.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #129

          Ja Scvej, det har han i hvert fald tidligere sagt at han vil "Mellemmændene, de såkaldte PBM’er, skal ud af ligningen, lyder det fra USA’s kommende præsident."

          1 Reply Last reply
          0
          • B Offline
            B Offline
            Bjæssing09
            wrote on sidst redigeret af
            #130

            Man skal sidde på hænderne her og supplere, hvis man har lidt på kistebunden. Novo skal nok rejse sig igen........

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Stockwatch1
              wrote on sidst redigeret af
              #131

              UBS:
              Discontinuations in STEP UP were lower than in STEP 1 according to our conversations
              with the company, which indicates that tolerability was reasonable. The study allowed
              for some flexibility in dosing, but not to the extent of the REDEFINE dosing regimens (the
              company state the STEP UP is more similar to the original STEP dosing regimens than vs
              REDEFINE)

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Stockwatch1
                wrote on sidst redigeret af
                #132

                In terms of % of patients that finished on the top dose, Novo state that it
                was lower for 7.2mg vs 2.4mg but have not provided numbers

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Stockwatch1
                  wrote on sidst redigeret af
                  #133

                  Pushback from the results is that this step up in efficacy for sema reduces the need for
                  CagriSema and does not extend the semaglutide patent cliff. We still see CagriSema as
                  another step ahead of efficacy, with REDEFINE-1 providing 2% additional weight loss
                  despite the more flexible dosing regimens and could provide further differentiation in
                  type-2 diabetics and comorbidities.

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Stockwatch1
                    wrote on sidst redigeret af
                    #134

                    We
                    see the results as providing a boost for the longer term Wegovy franchise, albeit does
                    not extend patent life. We expect any decision on filing and launch to take account of
                    the supply situation, but we would expect any regulatory review to be only c.6 months
                    given it is a supplemental dosage and not a new indication.

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Stockwatch1
                      wrote on sidst redigeret af
                      #135

                      UBS' kommentarer til dagens data, netop udsendt

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #136

                        tak Sw

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          koden
                          wrote on sidst redigeret af
                          #137

                          Da de mest pessimistiske analytikere satte kursmål 5xx tilbage i sommers, da tænkte jeg de havde fis i kasketten. Men må sige de fik ret.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #138

                            Novo er ramt af usikkerhed vurderer Sydbank: Prisforhandlinger bør ikke overraske https://proinvestor.com/investornyt/1266560/novo-er-ramt-af-usikkerhed-vurderer-sydbank-prisforhandlinger-bor-ikke-overraske

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #139

                              Video - Novo Nordisk aktieanalyse! Købsmulighed? https://proinvestor.com/boards/124284

                              1 Reply Last reply
                              0
                              • H Offline
                                H Offline
                                Hansen
                                wrote on sidst redigeret af
                                #140

                                Fra bioSpace https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial?_gl=1*1t5e3kc*_up*MQ.._gaMTQ4OTIxMjQ1Ni4xNzM3MjcwOTI2*_ga_Q90M6MWJZ4*MTczNzI3MDkyNC4xLjAuMTczNzI3MTExNi4wLjAuMA..

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #141

                                  Novo Nordisk: Det halvfyldte glas er blevet halvt tomt https://proinvestor.com/boards/124293

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    JKY_VH
                                    wrote on sidst redigeret af
                                    #142

                                    Nordea gentager køb og kursmål 977 We reiterate Buy with an unchanged DCF-derived target of DKK 977 per share

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #143

                                      Novo Nordisks fald i dag, det er virkelig vildt at være vidne til ...

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        koden
                                        wrote on sidst redigeret af
                                        #144

                                        LLY er også nede i dag. Men ja vildt og helt i skoven.

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Riis7
                                          wrote on sidst redigeret af
                                          #145

                                          usa er lukket , MLK dag i usa
                                          , LLY er fra i fredags

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper